Brief: Immuron New U.S. Department Of Defense Award & Clinical Trial Update
Dec 3 (Reuters) - Immuron Ltd IMC.AX: IMMURON NEW U.S. DEPARTMENT OF DEFENSE AWARD & CLINICAL TRIAL UPDATE IMMURON LTD - TO PRODUCE TWO HYPER-IMMUNE BOVINE COLOSTRUM PRODUCTS IMMURON LTD - RESEARCH AGREEMENT FUNDED BY U.S. DEPARTMENT OF DEFENSE SUBAWARD Source text: ID:nGNX4CwnPB Further company coverage: IMC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million